Delivery Order SPE2DB22D1002-SPE2DB25FLCH0
Award Date
5/16/25
Potential Completion Date
5/19/25
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567584246 - DAPAGLIFLOZIN 10 MG TABLET 30S. The contract has a ceiling value of $1,889.47 and an ultimate completion date of March 17, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used for diabetes management. The contract has a ceiling value of $4,944.28 and is a firm fixed price delivery order contract with a completion date of December 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,334.86 firm fixed-price contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product, with a completion date of December 3, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,762.40, is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of March 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for DAPAGLIFLOZIN 10 MG TABLET 30S, a prescription medication. The contract has a ceiling value of $9,525.15 and a period of performance through March 2025. The contract is a firm fixed price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a diabetes medication, with a ceiling value of $22,799.14 and a period of performance through May 19, 2025. The contract is not set aside and is a firm-fixed price type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,961.68, is for the delivery of 4,568,120 units of the prescription medication dapagliflozin 10 mg tablets. The contract is a firm fixed-price, non-set-aside award with a completion date of May 5, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a prescription medication. The contract has a firm fixed price of $1,416.72 and a completion date of May 19, 2025. This appears to be a non-set-aside contract, meaning it was awarded through open competition. Amerisourcebergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPAGLIFLOZIN 5 MG TABLET 30S, a medication used for the treatment of diabetes. The contract has a firm fixed price of $4,937.87 and a completion date of February 14, 2025. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4566322571 DAPAGLIFLOZIN 10 MG TABLET 30S. The $8,563.20 firm fixed-price contract has an ultimate completion date of November 5, 2024 and is not set aside for any specific business category. AmerisourceBergen, a for-profit organization and registered SAM.gov vendor, has an extensive track record of federal contract awards,...